نتایج جستجو برای: polio vaccine

تعداد نتایج: 111169  

2017
Yuhong Xiao Henry Daniell

Oral polio vaccine (OPV) and Inactivated Polio Vaccine (IPV) have distinct advantages and limitations. IPV does not provide mucosal immunity and introduction of IPV to mitigate consequences of circulating vaccine-derived polio virus from OPV has very limited effect on transmission and OPV campaigns are essential for interrupting wild polio virus transmission, even in developed countries with a ...

2012
Markus A Rose Christine Juergens

Enclosed for your consideration for publication in BMC Pediatrics is the original manuscript, “An open-label randomized clinical trial in children of prophylactic paracetamol co-administered with 7-valent pneumococcal conjugate vaccine and hexavalent diphtheria toxoid, tetanus toxoid, 3-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b vaccine.”

Journal: :JAMA 2010
Heidi J Larson David L Heymann

IN JUNE 2009, THE WORLD HEALTH ORGANIZATION (WHO) declared the 2009 influenza A(H1N1) pandemic and in October 2009, President Obama declared it a national emergency. The influenza A(H1N1) virus is being monitored around the world for changes in virulence or epidemiology. There has been a push to have vaccines ready, yet vaccine supply may be insufficient in some areas. The public wants to be as...

Journal: :Indian pediatrics 2004
Vipin M Vashishtha

INDIAN PEDIATRICS 204 VOLUME 41FEBRUARY 17, 2004 from about 1968. The very reasons for multiple doses of OPV and the need for pulse immunization are the occurrence of vaccine failure of three doses of OPV. Dr Paul is not on firm grounds when he declares that polio cannot be eradicated without first discovering the reason(s) for vaccine failure. Vaccine failure can be overcome by increasing the ...

2016
Rajni Gunnala Ikechukwu U Ogbuanu Oluwasegun J Adegoke Heather M Scobie Belinda V Uba Kathleen A Wannemuehler Alicia Ruiz Hashim Elmousaad Chima J Ohuabunwo Mahmud Mustafa Patrick Nguku Ndadilnasiya Endie Waziri John F Vertefeuille

BACKGROUND Despite recent success towards controlling poliovirus transmission, Nigeria has struggled to achieve uniformly high routine vaccination coverage. A lack of reliable vaccination coverage data at the operational level makes it challenging to target program improvement. To reliably estimate vaccination coverage, we conducted district-level vaccine coverage surveys using a pre-existing i...

Journal: :Journal of epidemiology and community health 1998
K Anand S Kant G Kumar S K Kapoor

India is committed to eradication of poliomyelitis by the year 2000. However, India still reported about 58% of all polio cases documented globally in 1995. India has adopted the World Health Organisation’s recommended strategy of National Immunization Days (that is, Pulse Polio Immunization) from the year 1995. Oral polio vaccine (OPV) was introduced at national level in 1985. However, no comm...

Journal: :Mayo Clinic proceedings 2000
G A Poland R M Jacobson

Nonetheless, despite these public health triumphs, vaccines can and do occasionally cause harm. For example, the widespread use of the polio vaccine resulted in vaccine-associated paralytic polio in 1 of every 2.4 million vaccine recipients. For this reason, calls for alternate schedules and cessation of the use of this vaccine began in the mid-1980s. 7 Indeed, the Advisory Committee on Immuniz...

Journal: :Risk analysis : an official publication of the Society for Risk Analysis 2006
Kimberly M Thompson

In 1988, when the World Health Assembly committed to globally eradicate wild polioviruses by the year 2000, no comprehensive models existed to support rigorous policy analyses that could project the human or financial resources that would be required. However, clear demonstration of an effective strategy for polio eradication by the Pan American Health Organization (PAHO) led world health leade...

Journal: :The Journal of infectious diseases 2006
Olen Kew

The 15-decade drive to control and eradicate polio through immunization [1] has benefited from the availability of 2 excellent vaccines, the inactivated poliovirus vaccine (IPV) of Salk and colleagues, licensed in 1955, and the live attenuated oral poliovirus vaccine (OPV) of Sabin, licensed in 1961. The 2 vaccines have complementary advantages, and both have played—and continue to play—importa...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید